Two recently published studies report that, in glioma, up-regulation of KIF3C is associated with patients’ unfavorable prognosis; functionally, KIF3C can regulate the PI3K/AKT/mTOR signal pathway to inhibit glioma cell growth [6,19]. This evidence concerns the gene MTOR and central nervous system cancer.